Proxy Votes Now

Home › Funds › 5439 Payden Equity Income Fund

5439 Payden Equity Income Fund (PYVAX) proxy voting record 2025-2026

Fund family: PAYDEN & RYGEL INVESTMENT GROUP · Filed by PAYDEN & RYGEL INVESTMENT GROUP (CIK 885709) · SEC series S000011766

Share classes and tickers: PYVAX (C000110231), PYVLX (C000032191), PYVSX (C000146917)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 952 with, 85 against, 22 abstentions (not counted as with management). Shareholder proposals: 37 FOR, 48 AGAINST, 21 abstained, by the filing’s own vote-source field.

No item-level comparison with other PAYDEN & RYGEL INVESTMENT GROUP funds is possible: fewer than three other funds of the family voted in 2025-2026.

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 94.8% of this fund’s 1,059 such votes could be given a sector; the other 55 (5.2%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Technology1882814.9%
Consumer Discretionary1602314.4%
Finance15885.1%
Industrials15642.6%
Health Care112108.9%
Utilities5735.3%
Real Estate5211.9%
Consumer Staples4924.1%
Energy29310.3%
Telecommunications2827.1%
Basic Materials1516.7%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections7480
Audit-related730
Say-on-Pay670
Corporate Governance3522
Capital Structure301
Compensation265
Other Social Issues2314
Environment or Climate1911
Human Rights or Human Capital/workforce1513
Shareholder Rights and Defenses1513

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Alphabet Inc.June 5, 2026$37M230
JPMorgan Chase & Co.May 19, 2026$35M171
McKesson CorporationJuly 30, 2025$31M140
Amazon.com, Inc.May 20, 2026$30M174
Merck & Co., Inc.May 26, 2026$27M183
Morgan StanleyMay 14, 2026$27M181
Analog Devices, Inc.March 11, 2026$24M141
Cisco Systems, Inc.December 16, 2025$24M130

Notable votes against management

MeetingCompanyProposalFundMgmt
May 19, 2026JPMorgan Chase & Co.Independent board chairman Shareholder proposalForAgainst
May 20, 2026Amazon.com, Inc.Shareholder Proposal Requesting A Report On Charitable Partnerships Shareholder proposalAgainstFor
May 20, 2026Amazon.com, Inc.Shareholder Proposal Requesting Additional Reporting On Impact Of Data Centers On Climate Commitments Shareholder proposalAgainstFor
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposalAgainstFor
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposalAgainstFor
May 14, 2026Morgan StanleyShareholder proposal requesting an independent Board Chairman Shareholder proposalForAgainst
March 11, 2026Analog Devices, Inc.To consider a shareholder proposal, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
May 27, 2026Chevron CorporationAdopt an Independent Chair Shareholder proposalForAgainst
May 27, 2026Chevron CorporationReport on Indigenous Peoples Rights Shareholder proposalAgainstFor
May 5, 2026GE AerospaceShareholder Proposal Regarding Right to Act by Written Consent Shareholder proposalForAgainst
May 5, 2026GE AerospaceShareholder Proposal Requesting Report on Defense-Related Products Shareholder proposalAgainstFor
May 14, 2026CVS Health CorporationStockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. Shareholder proposalForAgainst

Search this fund’s votes by company

1,061 ballot items at 70 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, 5439 Payden Equity Income Fund (PYVAX) voted at 70 shareholder meetings of 69 companies, on 1,061 ballot items in all. Where management made a recommendation, the fund followed it on 89.9% of the items and voted against it 85 times. Its most frequent area of disagreement was corporate governance (22 of its votes against management). It voted FOR 43.5% of the 85 shareholder proposals on which it cast a FOR or AGAINST vote.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.